The global lab automation market is expected to witness a steady growth during the forecast period owing to an increasing gap between the demand for laboratory procedures and availability of trained laboratory personnel. The high accuracy and reproducibility obtained through lab automation are among the major advantages affecting the market positively. Other drivers expected to fuel the growth of this market are personnel safety, smaller volumes of sample and reagents required, miniaturization of the process leading to low reagent cost, progressing drug discovery and clinical diagnostics. The market is expected to witness lucrative opportunities for growth owing to an increasing prevalence of infectious diseases and rising number of clinical studies which are expected to increase the number of diagnostic tests performed in the laboratories.
The lab automation market is classified on the basis of equipment and software, types of automations, applications and end-use. Equipments can be further segmented into automatic liquid handling, micro plate readers, stand alone robots, software and informatics, automatic storage and retrieval system. Partial, modular and total lab automations are available for clinical diagnostic, genomic, drug discovery and proteomic solutions. Research institutes, hospitals, private laboratories, biotechnology and pharmaceuticals users are the final consumers for this market. Owing to the increasing technological complexity of the laboratory automaton equipment it is expected that equipment and software segment will witness significant demand during the forecast period. The development of fully automated robotic liquid handling machines will provide laboratories with the required large scale processing capabilities and thus are expected to further fuel the growth of this market till 2020
Geographically, lab automation market is segmented into North America, Europe, Asia Pacific and RoW. North America dominated the market in 2013. The large share can primarily be attributed to the growing applications of lab automation in drug development and clinical laboratory functions in the region. With the rise in R&D expenditure in Asia Pacific, it is expected to witness a lucrative growth in the coming six years. The key players in lab automation market are Hamilton Robotics, Danaher (Beckman Coulter & Molecular devices), Tecan Group Ltd, PerkinElmer Inc., Thermo Fisher Scientifics Inc., BMG Labtech GmbH, Aurora Biomed Inc., Hudson Robotics, Siemen Healthcare, Roche Diagnostics, Agilents Technologies Inc., Bio Tek Instruments Inc. Eppendorf and Qiagen.
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.